238.97
price down icon1.35%   -3.26
after-market Handel nachbörslich: 238.97
loading

Finanzdaten der Resmed Inc-Aktie (RMD)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.25%
1,463.65
1,431.41 1,422.81 1,335.58 1,347.99
Cost Of Revenue
11.47%
602.43
540.43 544.08 514.76 527.92
Gross Profit
3.34%
861.22
890.98 878.72 820.82 820.07
Operating Expenses
5.45%
412.51
391.17 387.06 374.28 365.53
Operating Income/Loss
10.22%
448.71
499.81 491.66 446.54 454.54
Nonoperating Income/Loss
917.27%
25.45
2.502 4.488 0.256 3.513
Income/Loss From Equity Method Investments
29.98%
2.233
1.718 1.515 1.489 1.269
Income/Loss From Continuing Operations Before Tax
5.60%
474.16
502.31 496.15 446.79 458.05
Income Tax Expense/Benefit
12.40%
90.73
103.58 103.56 98.26 78.35
Net Income/Loss
3.84%
383.43
398.73 392.59 348.54 379.70
Common Stock Dividends
0.00%
0.60
0.60 0.60 0.60 0.53
ALC ALC
$66.18
price down icon 0.60%
$35.96
price down icon 1.67%
WST WST
$384.02
price up icon 0.26%
BDX BDX
$191.75
price down icon 1.04%
$85.81
price down icon 2.33%
BAX BAX
$25.28
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):